Stock Track | Hims & Hers Health Plunges 5.87% in Pre-market on Q1 Loss, GLP-1 Transition and Convertible Notes Offering

Stock Track

May 18

Hims & Hers Health Inc. (HIMS) experienced a pre-market plunge of 5.87% on Monday, extending a multi-session selloff.

The sustained downside pressure follows the company's disappointing first-quarter results, which revealed an unexpected net loss of $92 million compared to $50 million a year ago, translating to a per-share loss of $0.40 versus analyst expectations for a profit. Revenue of $608 million also missed Wall Street estimates, with Americas revenue declining 8% year-over-year.

Additionally, the company's strategic pivot away from higher-margin compounded GLP-1 medications toward branded products at lower margins continues to weigh on sentiment. Concurrently, Hims & Hers announced a proposed $300 million convertible senior notes offering with a $45 million upsize option, with proceeds intended to support international expansion, the Eucalyptus acquisition, and technology and AI investments, which may have contributed to the downward pressure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1194145692"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1194145692\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1194145692?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-18 19:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1194145692","market":"sg","top_or_hot":-1,"title":"Stock Track | Hims & Hers Health Plunges 5.87% in Pre-market on Q1 Loss, GLP-1 Transition and Convertible Notes Offering","media":"Stock Track","content":"<p>Hims & Hers Health Inc. (HIMS) experienced a pre-market plunge of 5.87% on Monday, extending a multi-session selloff.</p><p>The sustained downside pressure follows the company's disappointing first-quarter results, which revealed an unexpected net loss of $92 million compared to $50 million a year ago, translating to a per-share loss of $0.40 versus analyst expectations for a profit. Revenue of $608 million also missed Wall Street estimates, with Americas revenue declining 8% year-over-year.</p><p>Additionally, the company's strategic pivot away from higher-margin compounded GLP-1 medications toward branded products at lower margins continues to weigh on sentiment. Concurrently, Hims & Hers announced a proposed $300 million convertible senior notes offering with a $45 million upsize option, with proceeds intended to support international expansion, the Eucalyptus acquisition, and technology and AI investments, which may have contributed to the downward pressure.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Hims & Hers Health Plunges 5.87% in Pre-market on Q1 Loss, GLP-1 Transition and Convertible Notes Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Hims & Hers Health Plunges 5.87% in Pre-market on Q1 Loss, GLP-1 Transition and Convertible Notes Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-18 19:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hims & Hers Health Inc. (HIMS) experienced a pre-market plunge of 5.87% on Monday, extending a multi-session selloff.</p><p>The sustained downside pressure follows the company's disappointing first-quarter results, which revealed an unexpected net loss of $92 million compared to $50 million a year ago, translating to a per-share loss of $0.40 versus analyst expectations for a profit. Revenue of $608 million also missed Wall Street estimates, with Americas revenue declining 8% year-over-year.</p><p>Additionally, the company's strategic pivot away from higher-margin compounded GLP-1 medications toward branded products at lower margins continues to weigh on sentiment. Concurrently, Hims & Hers announced a proposed $300 million convertible senior notes offering with a $45 million upsize option, with proceeds intended to support international expansion, the Eucalyptus acquisition, and technology and AI investments, which may have contributed to the downward pressure.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HIMS","symbol_name":"Hims & Hers Health Inc.","start_time":0,"source_url":"","article_id":"1194145692","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1194145692","pubTimestamp":1779103159,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Hims & Hers Health Inc. (HIMS) experienced a pre-market plunge of 5.87% on Monday, extending a multi-session selloff.The sustained downside pressure follows the company's disappointing first-quarter...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HIMS":"Hims & Hers Health Inc."},"translate_title":"个股追踪|Hims&Hers Health盘前暴跌5.87%，因Q1亏损、GLP-1过渡和可转换票据发行","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HIMS":1},"content_text":"Hims & Hers Health Inc. (HIMS) experienced a pre-market plunge of 5.87% on Monday, extending a multi-session selloff.The sustained downside pressure follows the company's disappointing first-quarter results, which revealed an unexpected net loss of $92 million compared to $50 million a year ago, translating to a per-share loss of $0.40 versus analyst expectations for a profit. Revenue of $608 million also missed Wall Street estimates, with Americas revenue declining 8% year-over-year.Additionally, the company's strategic pivot away from higher-margin compounded GLP-1 medications toward branded products at lower margins continues to weigh on sentiment. Concurrently, Hims & Hers announced a proposed $300 million convertible senior notes offering with a $45 million upsize option, with proceeds intended to support international expansion, the Eucalyptus acquisition, and technology and AI investments, which may have contributed to the downward pressure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}